Assembly Biosciences Inc.

ASMB | NASDAQ

Price Alert Chart Builder DCF Calculator

$25.61

+$0.17 (+0.67%)

Sep 22, 2026, 11:07 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.67%

(1D)

Rating

Updated: Aug 25, 2026

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $507.62M

1D Range

25.25 25.89

52W Range

21.80 39.71

Valuation (TTM)

PE 46.25

PB 1.65

EV/EBITDA -76.32

Valuation (NTM)

Forward PE 12.31

Forward PEG 0.12

Price Target $51.67

Cash Flow

FCF Yield -7.7%

SBC Adj. FCF Yield -9.0%

SBC Impact -17.3%

Margins

Gross Margin 77.7%

Operating Margin -14.3%

FCF Margin -62.7%

Growth (CAGR)

Revenue 3Y | 5Y 51.6% | 11.5%

Dil EPS 3Y | 5Y 100.8% | 57.0%

FCF 3Y | 5Y -133.7% | 24.0%

Returns

ROA 0.0%

ROE 0.0%

ROIC -2.9%

Financial Health

Net Cash

$318.01M

Current Ratio 13.99

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Assembly Biosciences, Inc. is a biotechnology firm in the clinical development phase, dedicated to identifying and advancing innovative therapeutic solutions for hepatitis B virus (HBV) infections wit...

Sector Healthcare

Industry Biotechnology

Employees 73

IPO Date Dec 16, 2010

Website www.assemblybio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$52

Upside

+103.05%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞